Troponin-I elevation in a young man with arrhythmogenic right ventricular dysplasia/cardiomyopathy

Journal of Interventional Cardiac Electrophysiology

Volumn 22, Issue 1, 2008, Pages 49-53

  Kostis, William J ^a   Tedford, Ryan J ^a   Miller, Daniel L ^a   Schulman, Steven P ^a   Tomaselli, Gordon F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Tachycardia; Troponin I elevation; Ventricular arrhythmias

Indexed keywords

AMIODARONE; BUSPIRONE; DIAZEPAM; ESMOLOL; LEVOTHYROXINE; METOPROLOL; NITRATE; QUINAPRIL; SOTALOL; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DEFIBRILLATION; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHIES; CORONARY ANGIOGRAPHY; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; MALE; TACHYCARDIA, VENTRICULAR; TROPONIN I;

EID: 44749091964     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-008-9250-1     Document Type: Article

References (25)

1. Calkins, H. (2006). Arrhythmogenic right-ventricular dysplasia/ cardiomyopathy. Current Opinion in Cardiology, 21, 55-63.
2. Dungan, W. T., Garson, A., Jr. & Gillette, P. C. (1981). Arrhythmogenic right ventricular dysplasia: a cause of ventricular tachycardia in children with apparently normal hearts. American Heart Journal, 102, 745-750.
3. Marcus, F. I., Fontaine, G. H., Guiraudon, G., et al. (1982). Right ventricular dysplasia: a report of 24 adult cases. Circulation, 65, 384-398.
4. Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. New England Journal of Medicine, 318, 129-133.
5. Sen-Chowdhry, S., Syrris, P., Ward, D., Asimaki, A., Sevdalis, E., & McKenna, W. J. (2007). Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation, 115, 1710-1720.
6. Awad, M. M., Dalal, D., Tichnell, C., et al. (2006). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27, 1157 DOI 10.1002/humu.9461.
7. Frank, R., Fontaine, G., Vedel, J., et al. (1978). Electrocardiologie de quatre cas de dysplasie ventriculaire droite arhythmogene. Archives des Maladies du coeur et des Vaisseaux, 71, 963-972 Medline.
8. McKenna, W. J., Thiene, G., Nava, A., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the working group myocardial and pericardial disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. British Heart Journal, 71, 215-218.
9. Corrado, D., Leoni, L., Link, M. S., et al. (2003). Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation, 108, 3084-3091.
10. Fontaine, G., Frank, R., Rougier, I., Tonet, J. L., Gallais, Y., Farenq, G., et al. (1989). Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenic right ventricular dysplasia: experience of 13 patients with a mean follow-up of 45 months. European Heart Journal, 10(Suppl D), 74-81.
11. Dalal, D., Jain, R., Tandri, H., et al. (2007). Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 432-440.
12. Nazarian, S., Roguin, A., Zviman, M. M., et al. (2006). Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation, 114, 1277-1284.
13. Dalal, D., Nasir, K., Bomma, C., et al. (2005). Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation, 112, 3823-3832.
14. Michaels, P. J., Kobashigawa, J. A., Child, J. S., & Fishbein, M. C. (2000). Chronic right-sided myocarditis mimicking arrhythmogenic right ventricular dysplasia. Human Pathology, 31, 618-621.
15. Tandri, H., Castillo, E., Ferrari, V. A., et al. (2006). Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. Journal of the American College of Cardiology, 48, 2277-2284.
16. Machado, M. N., Suzuki, F. A., Mouco, O. C., Hernandes, M. E., Lemos, M. A., & Maia, L. N. (2005). Positive troponin T in a chagasic patient with sustained ventricular tachycardia and no obstructive lesions on cine coronary angiography. Arquivos Brasileiros de Cardiologia, 84, 182-184.
17. Yeo, K. K., Cruz, L., & Hong, R. (2006). Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease. Hawaii Medical Journal, 65, 86-87.
18. Saenz, A. J., Lee-Lewandrowski, E., Wood, M. J., et al. (2006). Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon. American Journal of Clinical Pathology, 126, 185-189.
19. Perseghin, G., De Cobelli, F., Esposito, A., et al. (2007). Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: a magnetic resonance imaging and phosphorus 31 spectroscopy study. American Heart Journal, 154, 937-942.
20. Hasdemir, C., Shah, N., Rao, A. P., et al. (2002). Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. Journal of Cardiovascular Electrophysiology, 13, 144-150.
21. Hurst, T. M., Hinrichs, M., Breidenbach, C., Katz, N., & Waldecker, B. (1999). Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. Journal of the American College of Cardiology, 34, 402-408.
22. Schlüter, T., Baum, H., Plewan, A., & Neumeier, D. (2001). Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clinical Chemistry, 47, 459-463.
23. Mallat, Z., Tedgui, A., Fontaliran, F., Frank, R., Durigon, M., & Fontaine, G. (1996). Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. New England Journal of Medicine, 335, 1224-1226.
24. Setsuta, K., Seino, Y., Ogawa, T., Ohtsuka, T., Seimiya, K., & Takano, T. (2004). Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. Circulation Journal, 68, 747-750.
25. Baumwart, R. D., Orvalho, J., & Meurs, K. M. (2007). Evaluation of serum cardiac troponin I concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy. American Journal of Veterinary Research, 68, 524-528.